Nasus Pharma Ltd (NSRX) › RevenueNasus Pharma Ltd (NSRX) — RevenueAnnual figures by fiscal year, from SEC filings.Fiscal YearRevenueChange YoY2025$1.24B—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share